Orbimed Advisors LLC Edgewise Therapeutics, Inc. Transaction History
Orbimed Advisors LLC
- $3.21 Billion
- Q1 2025
A detailed history of Orbimed Advisors LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 15,021,721 shares of EWTX stock, worth $201 Million. This represents 10.3% of its overall portfolio holdings.
Number of Shares
15,021,721
Previous 15,021,721
-0.0%
Holding current value
$201 Million
Previous $401 Million
17.6%
% of portfolio
10.3%
Previous 10.86%
Shares
4 transactions
Others Institutions Holding EWTX
# of Institutions
222Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Ra Capital Management, L.P. Boston, MA8.91MShares$119 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$87.7 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$82.4 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$80.6 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75.35MShares$71.6 Million10.59% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $846M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...